Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MedinCell: Publication of the Activity Report and Financial Information for the First Half-year (April - Sept. 2019)

BusinessWire_EN 
0 0 03.12.19
MedinCell: Publication of the Activity Report and Financial Information for the First Half-year (April - Sept. 2019)
 

MedinCell (Paris:MEDCL):

Progression of the portfolio with FDA IND clearance to initiate clinical activities for mdc-TJK and mdc-ANG entering preclinical

Launch of Animal Health activities

Revenue increase and strong cash position in line with expectations

Post-closing events

  • Up to 19 M$ grant from the Bill & Melinda Gates Foundation for mdc-WWM
  • Antipsychotic programs: confirmation of clinical activities start for the second long-acting injectable antipsychotic mdc-TJK and interim analysis for mdc-IRM Phase 3 in the second half of 2020

The information contained in this press release will be commented by the MedinCell management team during an online conference on December 3, 2019. The comments and answers to participants' questions will be available on invest.medincell.com

Press release related to half-year events is available on MedinCell’s website: https://invest.medincell.com/#news

View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005830/en/

Medincell S.a. Stock

€14.90
-2.600%
We can see a decrease in the price for Medincell S.a.. Compared to yesterday it has lost -€0.400 (-2.600%).

Show more
Like: 0
Share
BusinessWire_EN 
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments

Not a member yet? Sign up for free!